<code id='95A2B3BF18'></code><style id='95A2B3BF18'></style>
    • <acronym id='95A2B3BF18'></acronym>
      <center id='95A2B3BF18'><center id='95A2B3BF18'><tfoot id='95A2B3BF18'></tfoot></center><abbr id='95A2B3BF18'><dir id='95A2B3BF18'><tfoot id='95A2B3BF18'></tfoot><noframes id='95A2B3BF18'>

    • <optgroup id='95A2B3BF18'><strike id='95A2B3BF18'><sup id='95A2B3BF18'></sup></strike><code id='95A2B3BF18'></code></optgroup>
        1. <b id='95A2B3BF18'><label id='95A2B3BF18'><select id='95A2B3BF18'><dt id='95A2B3BF18'><span id='95A2B3BF18'></span></dt></select></label></b><u id='95A2B3BF18'></u>
          <i id='95A2B3BF18'><strike id='95A2B3BF18'><tt id='95A2B3BF18'><pre id='95A2B3BF18'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:55573
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          The biotech scorecard for Q1: 17 stock
          The biotech scorecard for Q1: 17 stock

          RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Ahead of JPM, here's who's profiting most in health care

          AdobeForalltheflaktheyget,thecountry’sfourbiggestpharmacybenefitmanagersreportedasurprisinglytameave